The U.S. cannabis market presents a significantly skewed risk-reward opportunity, particularly within the realm of multi-state operators (MSOs). As explained by authorChris IngrassiainTodd Harrison's"Cannabis Confidential" newsletter, the recent price actions have left many investors bewildered, especially in the wake of the proposed rescheduling of cannabis under the DEA's Controlled Substances Act from Schedule I to Schedule III.

U.S. MSOs: Evaluating The Investment Thesis

Why Add U.S. MSOs To Your Investment Portfolio?

Ingrassia goes over several key questions investors should ask themselves when evaluating U.S. MSOs. The first and...